Terms and Conditions

Download the pdf
General terms of use and conditions

The foregoing represents the General Terms of Use and Conditions applicable to Mirimus’ products, services or mice. Acceptance of delivery of products, services or mice, shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on Mirimus, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of products, services or mice by Mirimus.

«Mice» means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by Mirimus. «Products» means biological materials, including but not limited to DNA or RNA materials supplied by Mirimus, and their derivatives. «Recipient» or «Purchaser» means each recipient of mice, products or services provided by Mirimus including each institution, its employees and other researchers under its control.

Mice and Products produced for Purchaser remain property of Mirimus and are nonexclusively distributed under rights to patents and intellectual property licensed from various institutions. Any custom made product may be resold and delivered to additional Recipients without notice. Purchasers may purchase exclusive rights for a limited time period. Please inquire with Mirimus customer for further details.

Purchasers agree and acknowledge the following terms of use: Title to these mice and products and biological materials derived from them remains with Mirimus, Inc. Mice or products shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, (iii) provided to any agent or other third party to provide breeding or other services for resale, (iv) bred except to obtain embryos and fetuses for research purposes, or (v) subjected to reverse engineering. Acceptance of products, services or mice from Mirimus shall be deemed as agreement by recipient to these conditions, and departure from these conditions requires Mirimus’s prior written authorization.

NO LIABILITY

In no event shall Mirimus, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of mice, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts of negligence on the part of Mirimus, its agents or employees. Unless prohibited by law, in purchasing or receiving mice, products, or services from Mirimus, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges Mirimus from all such causes of action or damages, and further agrees to defend and indemnify Mirimus from any costs or damages arising out of third party claims.

Mice and products are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

NONDISCLOSURE OF CONFIDENTIAL INFORMATION

Mirimus shall respect the confidential information it may obtain regarding its customers and their technology, research developments and methods of doing business. All confidential information coming into Mirimus’ possession, including but not limited to files, records, documents, data, lists, and similar items shall emain the exclusive property of the customer and shall not be used by Mirimus except in the course of the performance of Mirimus’ Services.

NO GUARANTEE OF RESULT

Mirimus cannot guarantee any particular result. Acceptance of delivered mice, products or services shall be deemed acknowledges that Mirimus has made no promises about the outcome of Services, and no representation or warranty to purchaser has been made by Mirimus that any expected results will be achieved. Purchaser acknowledges and agrees and that any validated product does not constitute a guaranty that expected results will be achieved. More specifically, any custom ES cell line or ES-cell derived mice generated from a customized ES cell line will contain genetic combinations from various strains and may not fully capture the characterized phenotype of fully in-bred strains. Therefore, Mirimus cannot guarantee that customized mice will meet all the expectations. To ensure that Mirimus mice will meet the needs of individual research projects, Mirimus advises purchasers to independently perform tests on a small number of mice to determine the suitability for the purchaser’s purposes.

THE FOREGOING WARRANTY IS IN LIEU OF ANY AND ALL OTHER WARRANTIES RELATING TO THE SERVICES TO BE PERFORMED OR THE ACCURACY OF THE RESULTS OBTAINED, EXPRESSED OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR FOR NON-INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS.

INTELLECTUAL PROPERTY

Use of the Tetracycline controllable expression systems (the «Tet Technology») is covered by a series of patents which are proprietary to TET Systems GmbH & Co. KG. Academic research institutions are granted an automatic license with the purchase of this product to use the Tet Technology only for internal, academic research purposes, which license specifically excludes the right to sell, or otherwise transfer, the Tet Technology or its component parts to third parties. Notwithstanding the above, academic and not-for profit research institutions whose research using the Tet Technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from TET Systems in order to use the Tet Technology. In accepting this license, all users acknowledge that the Tet Technology is experimental in nature. TET Systems GmbH & Co. KG makes no warranties, express or implied or of any kind, and hereby disclaims any warranties, representations, or guarantees of any kind as to the Tet Technology, patents, or products. All others are invited to request a license from TET Systems GmbH & Co. KG prior to purchasing these reagents or using them for any purpose. Mirimus, Inc. is required by its licensing agreement to submit a report of all purchasers of the Tet-controllable expression system to TET Systems. For license information, please contact: GSF/CEO,TET Systems GmbH & Co. KG, Im Neuenheimer Feld 582,69120 Heidelberg, Germany Tel: +4962215880400, Fax: +4962215880404 eMail: info@tetsystems.com or use the electronic licensing request form via http://www.tetsystems.com/main_inquiry.htm.

Mirimus products contain proprietary nucleic acid(s) coding for a proprietary fluorescent protein(s) being, including its derivatives or modifications, the subject of pending patent applications and/or patents owned by Evrogen (hereinafter «Evrogen Fluorescent Proteins»). The purchase of Mirimus products containing Evrogen Fluorescent Proteins conveys to the buyer the non-transferable right to use Evrogen Fluorescent Proteins only for research conducted by the buyer. No rights are conveyed to modify or clone the gene encoding fluorescent protein contained in this product, to use the product for validating or screening compounds or to use Evrogen Fluorescent Proteins for commercial purposes. For information on commercial licensing, contract Evrogen Licensing Department, email: license@evrogen.com.

Use of short hairpin (shRNA) Technology is intellectual property under Cold Spring Harbor Laboratory Core IP. Academic/nonprofit research institutions are granted an automatic license with the purchase of this product to use the shRNA technology only for internal, academic research purposes, which license specifically excludes the right to sell, or otherwise transfer, the shRNA Technology or its component parts to third parties. Notwithstanding the above, academic and not-for profit research institutions whose research using the shRNA Technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from CSHL in order to use the Core IP. For license information, please contact the Office of Technology Transfer, Nichols Building, 1st Floor, Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, Phone: 516/367–8301, Fax: 516/367–8435, email: techtran@chsl.edu.

Mirimus Inc. is a registered trademark. All Rights Reserved.